We hereby submit Monitoring Agency Report for the quarter ended December 31, 2025 - IPO.
YATHARTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Yatharth Hospital has filed the Monitoring Agency Report from CARE Ratings for the quarter ended December 31, 2025, tracking the use of its IPO proceeds (issue size Rs. 610 crore, net monitored amount Rs. 569.71 crore). Of the total Rs. 569.71 crore, Rs. 521.26 crore has been utilised so far and Rs. 48.45 crore remains unutilised. Notably, no funds were deployed during Q3 FY26 itself – utilisation was flat across the quarter. The unutilised amount of Rs. 48.45 crore is parked mainly in Axis Bank fixed deposits (around Rs. 50 crore earning 5.90%) and in monitoring/public offer accounts. Most objects are fully utilised, but three are still ongoing with delays: subsidiary loan repayment (Rs. 2.28 crore pending), subsidiary hospital capex (Rs. 42.74 crore pending), and general corporate purposes (Rs. 3.43 crore pending). No material deviation from the stated objects was reported.
No fresh deployment of IPO money in Q3 FY26 means growth projects tied to subsidiary hospital expansion are still on the back burner, which may concern investors looking for execution on capex plans. However, the unutilised funds are safely parked in bank FDs and there are no deviations from the stated purposes, so the core use of IPO money remains on track with only timing delays.